A citation-based method for searching scientific literature

Sathish Babu Vasamsetti, Santosh Karnewar, Anantha Koteswararao Kanugula, Avinash Raj Thatipalli, Jerald Mahesh Kumar, Srigiridhar Kotamraju. Diabetes 2015
Times Cited: 200







List of co-cited articles
853 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.
Amy R Cameron, Vicky L Morrison, Daniel Levin, Mohapradeep Mohan, Calum Forteath, Craig Beall, Alison D McNeilly, David J K Balfour, Terhi Savinko, Aaron K F Wong,[...]. Circ Res 2016
264
15

Metformin treatment status and abdominal aortic aneurysm disease progression.
Naoki Fujimura, Jiang Xiong, Ellen B Kettler, Haojun Xuan, Keith J Glover, Matthew W Mell, Baohui Xu, Ronald L Dalman. J Vasc Surg 2016
67
17

Role of AMP-activated protein kinase in mechanism of metformin action.
G Zhou, R Myers, Y Li, Y Chen, X Shen, J Fenyk-Melody, M Wu, J Ventre, T Doebber, N Fujii,[...]. J Clin Invest 2001
11

Association between metformin prescription and growth rates of abdominal aortic aneurysms.
J Golledge, J Moxon, J Pinchbeck, G Anderson, S Rowbotham, J Jenkins, M Bourke, B Bourke, A Dear, T Buckenham,[...]. Br J Surg 2017
49
22


Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.
Kikuo Isoda, James L Young, Andreas Zirlik, Lindsey A MacFarlane, Naotake Tsuboi, Norbert Gerdes, Uwe Schönbeck, Peter Libby. Arterioscler Thromb Vasc Biol 2006
333
9


Editor's Choice - Metformin Prescription is Associated with a Reduction in the Combined Incidence of Surgical Repair and Rupture Related Mortality in Patients with Abdominal Aortic Aneurysm.
Jonathan Golledge, Dylan R Morris, Jenna Pinchbeck, Sophie Rowbotham, Jason Jenkins, Michael Bourke, Bernard Bourke, Paul E Norman, Rhonda Jones, Joseph V Moxon. Eur J Vasc Endovasc Surg 2019
25
36

Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population.
Nathan K Itoga, Kara A Rothenberg, Paola Suarez, Thuy-Vy Ho, Matthew W Mell, Baohui Xu, Catherine M Curtin, Ronald L Dalman. J Vasc Surg 2019
42
21

The mechanisms of action of metformin.
Graham Rena, D Grahame Hardie, Ewan R Pearson. Diabetologia 2017
675
9

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Marc Foretz, Sophie Hébrard, Jocelyne Leclerc, Elham Zarrinpashneh, Maud Soty, Gilles Mithieux, Kei Sakamoto, Fabrizio Andreelli, Benoit Viollet. J Clin Invest 2010
810
8

Association between diabetes and prevalence and growth rate of abdominal aortic aneurysms: A meta-analysis.
Jiang Xiong, Zhongyin Wu, Chen Chen, Yingqi Wei, Wei Guo. Int J Cardiol 2016
39
20

Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.
Chien-Yi Hsu, Yu-Wen Su, Yung-Tai Chen, Shih-Hung Tsai, Chun-Chin Chang, Szu-Yuan Li, Po-Hsun Huang, Jaw-Wen Chen, Shing-Jong Lin. Cardiovasc Diabetol 2016
41
19



Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis.
Farshad Forouzandeh, Gloria Salazar, Nikolay Patrushev, Shiqin Xiong, Lula Hilenski, Baowei Fei, R Wayne Alexander. J Am Heart Assoc 2014
76
10

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
David Preiss, Suzanne M Lloyd, Ian Ford, John J McMurray, Rury R Holman, Paul Welsh, Miles Fisher, Chris J Packard, Naveed Sattar. Lancet Diabetes Endocrinol 2014
113
8

Metformin: from mechanisms of action to therapies.
Marc Foretz, Bruno Guigas, Luc Bertrand, Michael Pollak, Benoit Viollet. Cell Metab 2014
611
7

Immune-mediated antitumor effect by type 2 diabetes drug, metformin.
Shingo Eikawa, Mikako Nishida, Shusaku Mizukami, Chihiro Yamazaki, Eiichi Nakayama, Heiichiro Udono. Proc Natl Acad Sci U S A 2015
292
7

Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.
Katrine L Kristensen, Anton Pottegård, Jesper Hallas, Lars M Rasmussen, Jes S Lindholt. J Vasc Surg 2017
20
35


Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission.
Qilong Wang, Miao Zhang, Gloria Torres, Shengnan Wu, Changhan Ouyang, Zhonglin Xie, Ming-Hui Zou. Diabetes 2017
165
7

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial.
John R Petrie, Nishi Chaturvedi, Ian Ford, Martijn C G J Brouwers, Nicola Greenlaw, Therese Tillin, Irene Hramiak, Alun D Hughes, Alicia J Jenkins, Barbara E K Klein,[...]. Lancet Diabetes Endocrinol 2017
149
7

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Hao Wu, Eduardo Esteve, Valentina Tremaroli, Muhammad Tanweer Khan, Robert Caesar, Louise Mannerås-Holm, Marcus Ståhlman, Lisa M Olsson, Matteo Serino, Mercè Planas-Fèlix,[...]. Nat Med 2017
577
7

Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction.
Juyoung Kim, Hyun Jeong Kwak, Ji-Young Cha, Yun-Seung Jeong, Sang Dahl Rhee, Kwang Rok Kim, Hyae Gyeong Cheon. J Biol Chem 2014
122
7

Metformin improves obesity-associated inflammation by altering macrophages polarization.
Yuanyuan Jing, Fan Wu, Dai Li, Lei Yang, Qi Li, Rong Li. Mol Cell Endocrinol 2018
78
8

Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation.
Olga Moiseeva, Xavier Deschênes-Simard, Emmanuelle St-Germain, Sebastian Igelmann, Geneviève Huot, Alexandra E Cadar, Véronique Bourdeau, Michael N Pollak, Gerardo Ferbeyre. Aging Cell 2013
234
7

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
Anila K Madiraju, Derek M Erion, Yasmeen Rahimi, Xian-Man Zhang, Demetrios T Braddock, Ronald A Albright, Brett J Prigaro, John L Wood, Sanjay Bhanot, Michael J MacDonald,[...]. Nature 2014
672
7

Metformin improves healthspan and lifespan in mice.
Alejandro Martin-Montalvo, Evi M Mercken, Sarah J Mitchell, Hector H Palacios, Patricia L Mote, Morten Scheibye-Knudsen, Ana P Gomes, Theresa M Ward, Robin K Minor, Marie-José Blouin,[...]. Nat Commun 2013
690
7

Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.
Yoshifumi Saisho. Endocr Metab Immune Disord Drug Targets 2015
220
7

Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism.
Filipe Cabreiro, Catherine Au, Kit-Yi Leung, Nuria Vergara-Irigaray, Helena M Cochemé, Tahereh Noori, David Weinkove, Eugene Schuster, Nicholas D E Greene, David Gems. Cell 2013
505
7

Metformin and reduced risk of cancer in diabetic patients.
Josie M M Evans, Louise A Donnelly, Alistair M Emslie-Smith, Dario R Alessi, Andrew D Morris. BMJ 2005
6

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.
M Y El-Mir, V Nogueira, E Fontaine, N Avéret, M Rigoulet, X Leverve. J Biol Chem 2000
933
6

Macrophages in the pathogenesis of atherosclerosis.
Kathryn J Moore, Ira Tabas. Cell 2011
6

AMPK activation reduces the number of atheromata macrophages in ApoE deficient mice.
Jing Wang, Ang Ma, Ming Zhao, Haibo Zhu. Atherosclerosis 2017
22
27

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
6

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Adriaan Kooy, Jolien de Jager, Philippe Lehert, Daniël Bets, Michiel G Wulffelé, Ab J M Donker, Coen D A Stehouwer. Arch Intern Med 2009
251
6

Metformin ameliorates the progression of atherosclerosis via suppressing macrophage infiltration and inflammatory responses in rabbits.
Qiangbing Yang, Hongming Yuan, Mao Chen, Jiali Qu, He Wang, Biao Yu, Jiahuan Chen, Shengnan Sun, Xiaochun Tang, Wenzhi Ren. Life Sci 2018
24
25

Metformin use and mortality among patients with diabetes and atherothrombosis.
Ronan Roussel, Florence Travert, Blandine Pasquet, Peter W F Wilson, Sidney C Smith, Shinya Goto, Philippe Ravaud, Michel Marre, Avi Porath, Deepak L Bhatt,[...]. Arch Intern Med 2010
244
6

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.
Jie Hong, Yifei Zhang, Shenghan Lai, Ankang Lv, Qing Su, Yan Dong, Zhiguang Zhou, Weili Tang, Jiajun Zhao, Lianqun Cui,[...]. Diabetes Care 2013
198
6

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.
Russell A Miller, Qingwei Chu, Jianxin Xie, Marc Foretz, Benoit Viollet, Morris J Birnbaum. Nature 2013
502
6

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis.
William W Wheaton, Samuel E Weinberg, Robert B Hamanaka, Saul Soberanes, Lucas B Sullivan, Elena Anso, Andrea Glasauer, Eric Dufour, Gokhan M Mutlu, Gr Scott Budigner,[...]. Elife 2014
574
6

Metformin Activates AMPK through the Lysosomal Pathway.
Chen-Song Zhang, Mengqi Li, Teng Ma, Yue Zong, Jiwen Cui, Jin-Wei Feng, Yu-Qing Wu, Shu-Yong Lin, Sheng-Cai Lin. Cell Metab 2016
112
6


Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
6


Repurposing Metformin for Cardiovascular Disease.
Graham Rena, Chim C Lang. Circulation 2018
44
11

Challenges and opportunities in limiting abdominal aortic aneurysm growth.
Jonathan Golledge, Paul E Norman, Michael P Murphy, Ronald L Dalman. J Vasc Surg 2017
71
7

Effect of AMPK signal pathway on pathogenesis of abdominal aortic aneurysms.
Le Yang, Lin Shen, Peixian Gao, Gang Li, Yuxiang He, Maohua Wang, Hua Zhou, Hai Yuan, Xing Jin, Xuejun Wu. Oncotarget 2017
22
22

AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE-/- mice.
Ang Ma, Jing Wang, Liu Yang, Yuanyuan An, Haibo Zhu. J Lipid Res 2017
36
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.